Absci

Absci

  • Founded in 2020
  • 201-500 Employees
  • $125M Venture Round on 2021-03

Careers at Absci


About Absci

Absci is a company focused on unlocking novel biology and creating better biologics using artificial intelligence (AI). They are advancing a pipeline of internal and partnered programs designed with generative AI, including an integrated drug creation platform that has designed a differentiated TL1A antibody for Inflammatory Bowel Disease. Absci seeks to transform the biologics drug discovery process which is traditionally long, costly, and prone to failure by using AI to uncover novel biology. The company partners with leaders in the pharmaceutical, tech, and academic sectors to develop biologics against challenging targets and employs AI models to optimize lead compounds and accelerate drug discovery. Their approach also involves AI-enabled novel target discovery using reverse immunology to identify antibodies and targets for AI optimization, aiming to bring life-changing medicines to patients more quickly.